MYC is a basic helix-loop-helix transcription factor that serves as a global regulator of gene expression and a major driver of human tumorigenesis 1. As a transcription factor, MYC binds DNA and activates transcription of growth-related genes, functioning through mechanisms that include promoting transcription termination upon RNA polymerase II stalling and coordinating transcription elongation with DNA replication and cell cycle progression 1. MYC regulates target genes through both site-specific chr8 remodeling at promoter regions and genome-wide modulation by controlling expression of epigenetic modifiers that alter chr8 structure 2. The protein possesses a large interactome including key partners like Max, TRRAP, and P-TEFb that provide mechanistic insight into its transcriptional activities 3. Deregulated MYC expression is a hallmark of malignant growth, inducing self-renewal of stem cells while blocking senescence and cell differentiation 2. MYC oncoproteins are implicated in approximately half of human cancers, with different MYC family members (c-myc, N-myc, L-myc) serving distinct roles and being associated with specific neoplastic diseases 4. Recent therapeutic approaches include protein drugs like Omomyc, which has shown success in human trials for solid tumors where traditional small-molecule approaches against MYC have failed 5.